• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Leucine rich adaptor protein 1 (LURAP1)

ACP13769

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP13769 Target NameLURAP1
Target SynonymsLURAP1; C1orf190; LRAP35A; LRP35A; Leucine rich adaptor protein 1; Leucine repeat adapter protein 35AFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-239
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ96LR2
Background Information
  • Uniprot Id

    Q96LR2

  • Target Species

    Human

  • Target Name

    LURAP1

  • Target Full Name

    Leucine rich adaptor protein 1

  • Target Function

    Acts as an activator of the canonical NF-kappa-B pathway and drive the production of proinflammatory cytokines. Promotes the antigen (Ag)-presenting and priming function of dendritic cells via the canonical NF-kappa-B pathway. In concert with MYO18A and CDC42BPA/CDC42BPB, is involved in modulating lamellar actomyosin retrograde flow that is crucial to cell protrusion and migration. Activates CDC42BPA/CDC42BPB and targets it to actomyosin through its interaction with MYO18A, leading to MYL9/MLC2 phosphorylation and MYH9/MYH10-dependent actomyosin assembly in the lamella.

  • Target Subcellular Location

    Cytoplasm.

  • Target Synonyms

    LURAP1; C1orf190; LRAP35A; LRP35A; Leucine rich adaptor protein 1; Leucine repeat adapter protein 35A

Inquire Recombinant Human Leucine rich adaptor protein 1 (LURAP1) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification